July 2, 2015 – The following post would constitute a perfect example how theragenomic and personalized medicine may help patients who carry genetic predispositions for sometimes rather debilitating and eventually fatal diseases. Thus, the U.S. Food and Drug Administration (FDA) today …

Theragenomic medicine: Orkambi approved by the FDA as a new treatment for cystic fibrosis Read more »